Limits...
In vitro drug release behavior from a novel thermosensitive composite hydrogel based on Pluronic f127 and poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) copolymer.

Gong CY, Shi S, Dong PW, Zheng XL, Fu SZ, Guo G, Yang JL, Wei YQ, Qian ZY - BMC Biotechnol. (2009)

Bottom Line: Chemical composition of composite hydrogel, initial drug loading, and hydrogel concentration substantially affected the drug release behavior.The higher Pluronic F127 content, lower initial drug loading amount, or lower hydrogel concentration resulted in higher cumulative release rate.The results showed that composite hydrogel prepared in this paper were biocompatible with low cell cytotoxicity, and the drugs in this work could be released slowly from composite hydrogel in an extended period, which suggested that the composite hydrogel might have great potential applications in biomedical fields.

View Article: PubMed Central - HTML - PubMed

Affiliation: State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, PR China. chygong14@yahoo.com.cn

ABSTRACT

Background: Most conventional methods for delivering chemotherapeutic agents fail to achieve therapeutic concentrations of drugs, despite reaching toxic systemic levels. Novel controlled drug delivery systems are designed to deliver drugs at predetermined rates for predefined periods at the target organ and overcome the shortcomings of conventional drug formulations therefore could diminish the side effects and improve the life quality of the patients. Thus, a suitable controlled drug delivery system is extremely important for chemotherapy.

Results: A novel biodegradable thermosensitive composite hydrogel, based on poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) (PEG-PCL-PEG, PECE) and Pluronic F127 copolymer, was successfully prepared in this work, which underwent thermosensitive sol-gel-sol transition. And it was flowing sol at ambient temperature but became non-flowing gel at body temperature. By varying the composition, sol-gel-sol transition and in vitro drug release behavior of the composite hydrogel could be adjusted. Cytotoxicity of the composite hydrogel was conducted by cell viability assay using human HEK293 cells. The 293 cell viability of composite hydrogel copolymers were yet higher than 71.4%, even when the input copolymers were 500 microg per well. Vitamin B12 (VB12), honokiol (HK), and bovine serum albumin (BSA) were used as model drugs to investigate the in vitro release behavior of hydrophilic small molecular drug, hydrophobic small molecular drug, and protein drug from the composite hydrogel respectively. All the above-mentioned drugs in this work could be released slowly from composite hydrogel in an extended period. Chemical composition of composite hydrogel, initial drug loading, and hydrogel concentration substantially affected the drug release behavior. The higher Pluronic F127 content, lower initial drug loading amount, or lower hydrogel concentration resulted in higher cumulative release rate.

Conclusion: The results showed that composite hydrogel prepared in this paper were biocompatible with low cell cytotoxicity, and the drugs in this work could be released slowly from composite hydrogel in an extended period, which suggested that the composite hydrogel might have great potential applications in biomedical fields.

Show MeSH

Related in: MedlinePlus

In vitro release behavior of VB12 from composite hydrogel. A: release behavior of S1, S4, an S6 hydrogel with the same hydrogel concentration (30 wt%) and initial drug loading amount (1 mg). B: release behavior of 30 wt% S3 hydrogel with different initial drug loading amount (1 mg and 2 mg). C: release behavior of 1 mg VB12 loaded S3 hydrogel with different hydrogel concentration (20 wt% and 30 wt%). Error bars represent the standard deviation (n = 3).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2654890&req=5

Figure 5: In vitro release behavior of VB12 from composite hydrogel. A: release behavior of S1, S4, an S6 hydrogel with the same hydrogel concentration (30 wt%) and initial drug loading amount (1 mg). B: release behavior of 30 wt% S3 hydrogel with different initial drug loading amount (1 mg and 2 mg). C: release behavior of 1 mg VB12 loaded S3 hydrogel with different hydrogel concentration (20 wt% and 30 wt%). Error bars represent the standard deviation (n = 3).

Mentions: In vitro release profile of VB12 from composite hydrogel in PBS was studied, and the results were shown in Fig. 5. According to Fig. 5, VB12 could be released in a sustained period. The hydrogel composition had great effect on VB12 release profile, and the results were shown in Fig. 5–A. S6 hydrogel disappeared completely in 12 hours with a cumulative release rate of approximately 94.2%, whereas S1 and S4 hydrogel could maintain their integrity in the whole release period. VB12 released faster and reached higher cumulative release rate (90.0%) from S3 hydrogel compared to S1 hydrogel (82.9%), which should be contributed to high composition (60 wt%) of fast-eroding Pluronic F127 in S3 hydrogel.


In vitro drug release behavior from a novel thermosensitive composite hydrogel based on Pluronic f127 and poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) copolymer.

Gong CY, Shi S, Dong PW, Zheng XL, Fu SZ, Guo G, Yang JL, Wei YQ, Qian ZY - BMC Biotechnol. (2009)

In vitro release behavior of VB12 from composite hydrogel. A: release behavior of S1, S4, an S6 hydrogel with the same hydrogel concentration (30 wt%) and initial drug loading amount (1 mg). B: release behavior of 30 wt% S3 hydrogel with different initial drug loading amount (1 mg and 2 mg). C: release behavior of 1 mg VB12 loaded S3 hydrogel with different hydrogel concentration (20 wt% and 30 wt%). Error bars represent the standard deviation (n = 3).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2654890&req=5

Figure 5: In vitro release behavior of VB12 from composite hydrogel. A: release behavior of S1, S4, an S6 hydrogel with the same hydrogel concentration (30 wt%) and initial drug loading amount (1 mg). B: release behavior of 30 wt% S3 hydrogel with different initial drug loading amount (1 mg and 2 mg). C: release behavior of 1 mg VB12 loaded S3 hydrogel with different hydrogel concentration (20 wt% and 30 wt%). Error bars represent the standard deviation (n = 3).
Mentions: In vitro release profile of VB12 from composite hydrogel in PBS was studied, and the results were shown in Fig. 5. According to Fig. 5, VB12 could be released in a sustained period. The hydrogel composition had great effect on VB12 release profile, and the results were shown in Fig. 5–A. S6 hydrogel disappeared completely in 12 hours with a cumulative release rate of approximately 94.2%, whereas S1 and S4 hydrogel could maintain their integrity in the whole release period. VB12 released faster and reached higher cumulative release rate (90.0%) from S3 hydrogel compared to S1 hydrogel (82.9%), which should be contributed to high composition (60 wt%) of fast-eroding Pluronic F127 in S3 hydrogel.

Bottom Line: Chemical composition of composite hydrogel, initial drug loading, and hydrogel concentration substantially affected the drug release behavior.The higher Pluronic F127 content, lower initial drug loading amount, or lower hydrogel concentration resulted in higher cumulative release rate.The results showed that composite hydrogel prepared in this paper were biocompatible with low cell cytotoxicity, and the drugs in this work could be released slowly from composite hydrogel in an extended period, which suggested that the composite hydrogel might have great potential applications in biomedical fields.

View Article: PubMed Central - HTML - PubMed

Affiliation: State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, PR China. chygong14@yahoo.com.cn

ABSTRACT

Background: Most conventional methods for delivering chemotherapeutic agents fail to achieve therapeutic concentrations of drugs, despite reaching toxic systemic levels. Novel controlled drug delivery systems are designed to deliver drugs at predetermined rates for predefined periods at the target organ and overcome the shortcomings of conventional drug formulations therefore could diminish the side effects and improve the life quality of the patients. Thus, a suitable controlled drug delivery system is extremely important for chemotherapy.

Results: A novel biodegradable thermosensitive composite hydrogel, based on poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) (PEG-PCL-PEG, PECE) and Pluronic F127 copolymer, was successfully prepared in this work, which underwent thermosensitive sol-gel-sol transition. And it was flowing sol at ambient temperature but became non-flowing gel at body temperature. By varying the composition, sol-gel-sol transition and in vitro drug release behavior of the composite hydrogel could be adjusted. Cytotoxicity of the composite hydrogel was conducted by cell viability assay using human HEK293 cells. The 293 cell viability of composite hydrogel copolymers were yet higher than 71.4%, even when the input copolymers were 500 microg per well. Vitamin B12 (VB12), honokiol (HK), and bovine serum albumin (BSA) were used as model drugs to investigate the in vitro release behavior of hydrophilic small molecular drug, hydrophobic small molecular drug, and protein drug from the composite hydrogel respectively. All the above-mentioned drugs in this work could be released slowly from composite hydrogel in an extended period. Chemical composition of composite hydrogel, initial drug loading, and hydrogel concentration substantially affected the drug release behavior. The higher Pluronic F127 content, lower initial drug loading amount, or lower hydrogel concentration resulted in higher cumulative release rate.

Conclusion: The results showed that composite hydrogel prepared in this paper were biocompatible with low cell cytotoxicity, and the drugs in this work could be released slowly from composite hydrogel in an extended period, which suggested that the composite hydrogel might have great potential applications in biomedical fields.

Show MeSH
Related in: MedlinePlus